Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Deferasirox Induces Apoptosis in Mantle Cell Lymphoma in a Mechanism Involving Cyclin-D1, p53 and the Ribonucleotide Reductase

Aladin Samara, BSc, MSc, Saar Shapira, MSc, Ido Lubin, PhD, Smadar Avigad, PhD, Pia Raanani, Galit Granot, PhD

Blood (2017) 130 (Supplement 1): 1481.

https://doi.org/10.1182/blood.V130.Suppl_1.1481.1481

Published: 2017

Journal Articles

Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia

Smadar Avigad, PhD, Keren Shichrur, PhD, Sara Elitzur, MD, Gil Gilad, MD, Shlomit Barzilai, MD, Galia Avrahami, MD, Nir Dotan, PhD, Jennifer Yarden, PhD, Isaac Yaniv, MD

Blood (2016) 128 (22): 1736.

https://doi.org/10.1182/blood.V128.22.1736.1736

Published: 2016

Journal Articles

Targeted Deep Sequencing of Genetic Alterations Identified By Whole Exome Sequencing Reveals Clonal Evolution in Pediatric T-Lymphoblastic Leukemia

Blood (2014) 124 (21): 491.

https://doi.org/10.1182/blood.V124.21.491.491

Published: 2014

Journal Articles

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3793.

https://doi.org/10.1182/blood.V124.21.3793.3793

Published: 2014

Journal Articles

Whole Exome Sequencing In Relapsed Pediatric T-ALL: Progression Into Relapse Is Characterized By An Increased Number Of Somatic Mutations and a Conservation Of Mutations In Leukemogenic Driver Genes

Joachim Kunz, MD, Tobias Rausch, PhD, Obul R Bandapalli, PhD, Martina U. Muckenthaler, PhD, Adrian M Stuetz, PhD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Rupert Handgretinger, Smadar Avigad, PhD, Jan Korbel, PhD, Andreas E. Kulozik, MD, PhD

Blood (2013) 122 (21): 228.

https://doi.org/10.1182/blood.V122.21.228.228

Published: 2013

Journal Articles

Genomic Heterogeneity In Pediatric Acute Lymphoblastic Leukemia

Isaac Yaniv, MD, Marta Jeison, PhD, Michal Hameiri-Grossman, PhD, Jacque Mardoukh, Nir Adam Sharon, Sarah Elitzur, MD, Gil Gilad, MD, Gali Avrahami, MD, Batia Stark, MD, Smadar Avigad, PhD

Blood (2013) 122 (21): 1389.

https://doi.org/10.1182/blood.V122.21.1389.1389

Published: 2013

Journal Articles

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Blood (2011) 118 (21): 2535.

https://doi.org/10.1182/blood.V118.21.2535.2535

Published: 2011

Journal Articles

Hypermethylation and Expression of Rassf1a in Childhood Acute Lymphoblastic Leukemia (ALL).

Isaac Yaniv, MD, Hadar Betzer, BA, Inna Naumov, MSc, Batia Stark, MD, Gali Avrahami, MD, Drorit Luria, PhD, Yona Kodman, Smadar Avigad, PhD

Blood (2007) 110 (11): 4141.

https://doi.org/10.1182/blood.V110.11.4141.4141

Published: 2007

Journal Articles

Collaboration between Activating Mutations in JAK2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS).

Blood (2007) 110 (11): LB6.

https://doi.org/10.1182/blood.V110.11.LB6.lb6

Published: 2007

Journal Articles

Minimal Residual Disease (MRD) Analysis in Non-MRD Based ALL IC-BFM 2002 Protocol for Childhood ALL: Is It Possible To Omit Minimal Residual Disease in Risk Stratification?.

Eva Fronkova, Smadar Avigad, Ki Wai Chik, Luis Castillo, Manor Sigal, Leona Reznickova, Katerina Zdrahalova, Tatana Skocovska, Martin Schrappe, Valentino Conter, Shai Izraeli, Chi Kong Li, Batia Stark, Ondrej Hrusak, Ester Mejstrikova, Jan Stary, Jan Trka

Blood (2006) 108 (11): 2271.

https://doi.org/10.1182/blood.V108.11.2271.2271

Published: 2006

Journal Articles

Minimal Disseminated Disease (MDD) in BM of Childhood T-Cell Lymphoblastic Lymphoma (Stage III), Detected by Flow Cytometry (FC) and Real Time Quantitative Polymerase Chain Reaction (RQ-PCR).

Batia Stark, MD, Drorit Luria, PhD, Sigal Manor, MSc, Taly Ronen, Yona Kodman, Gali Avrahami, MD, Isaac Yaniv, MD, Smadar Avigad, PhD

Blood (2005) 106 (11): 4660.

https://doi.org/10.1182/blood.V106.11.4660.4660

Published: 2005

NARROW

Deferasirox Induces Apoptosis in Mantle Cell Lymphoma in a Mechanism Involving Cyclin-D1, p53 and the Ribonucleotide Reductase

Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia

Targeted Deep Sequencing of Genetic Alterations Identified By Whole Exome Sequencing Reveals Clonal Evolution in Pediatric T-Lymphoblastic Leukemia

Prediction of Relapse By microRNA Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Whole Exome Sequencing In Relapsed Pediatric T-ALL: Progression Into Relapse Is Characterized By An Increased Number Of Somatic Mutations and a Conservation Of Mutations In Leukemogenic Driver Genes

Genomic Heterogeneity In Pediatric Acute Lymphoblastic Leukemia

Low Levels of Mir-151-5p and Mir-451 Predict Relapse in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Hypermethylation and Expression of Rassf1a in Childhood Acute Lymphoblastic Leukemia (ALL).

Collaboration between Activating Mutations in JAK2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS).

Minimal Residual Disease (MRD) Analysis in Non-MRD Based ALL IC-BFM 2002 Protocol for Childhood ALL: Is It Possible To Omit Minimal Residual Disease in Risk Stratification?.

Minimal Disseminated Disease (MDD) in BM of Childhood T-Cell Lymphoblastic Lymphoma (Stage III), Detected by Flow Cytometry (FC) and Real Time Quantitative Polymerase Chain Reaction (RQ-PCR).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only